Equitable Access to High-Cost Pharmaceuticals PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Equitable Access to High-Cost Pharmaceuticals PDF full book. Access full book title Equitable Access to High-Cost Pharmaceuticals by Zaheer-Ud-Din Babar. Download full books in PDF and EPUB format.
Author: Zaheer-Ud-Din Babar
Publisher: Academic Press
ISBN: 0128119624
Category : Medical
Languages : en
Pages : 240
Get Book Here
Book Description
Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines. - Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs - Incorporates existing guidelines and recommendations by international organizations - Compares and contrasts how different countries fund and police high-cost drug access - Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing - Reviews novel pharmaceuticals of current research interest
Author: Zaheer-Ud-Din Babar
Publisher: Academic Press
ISBN: 0128119624
Category : Medical
Languages : en
Pages : 240
Get Book Here
Book Description
Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines. - Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs - Incorporates existing guidelines and recommendations by international organizations - Compares and contrasts how different countries fund and police high-cost drug access - Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing - Reviews novel pharmaceuticals of current research interest
Author: Roger Scarlin Chennells
Publisher: Springer
ISBN: 3319197258
Category : Medical
Languages : en
Pages : 206
Get Book Here
Book Description
The main question explored by the book is: How can cross-border access to human genetic resources, such as blood or DNA samples, be governed in such a way as to achieve equity for vulnerable populations in developing countries? The book situates the field of genomic and genetic research within global health and research frameworks, describing the concerns that have been raised about the potential unfairness in exchanges during recent decades. Access to and sharing in the benefits of human biological resources are aspects not regulated by any international legal framework such as the Convention on Biological Diversity, which applies only to the exchange of plants, animals and microorganisms, as well as to associated traditional knowledge. Examples of genetic research perceived as exploitative are provided in order to illustrate the legal vacuum concerning the global governance of human genetic resources. The main conclusions drawn from the legal and ethical analysis are: • Benefit sharing is crucial in order to avoid the exploitation of developing countries in human genetic research. • With functioning research ethics committees, undue inducement is less of a concern in genetic research than in other areas of medical research (e.g. clinical trials). • Concerns remain over research involving indigenous populations; accordingly, recommendations are provided. In drawing these conclusions, the book addresses in detail a highly pressing topic in global bioethics and international law. In this regard, it combines bioethical arguments with jurisprudence, in particular with reference to the law of equity and the legal concepts of duress (coercion), unconscionable dealing, and undue inducement.
Author: Morten Walløe Tvedt
Publisher: IUCN
ISBN: 2831709806
Category : Convention on Biological Diversity
Languages : en
Pages : 172
Get Book Here
Book Description
Fewer than 11% of CBD Parties have adopted substantive ABS law, and nearly all of these are developing countries, focusing almost entirely on the 'access' side of the equation. Most of the CBD's specific ABS obligations, however, relate to the other side of the equation-benefit sharing. This book considers the full range of ABS obligations, and how existing tools in user countries' national law can be used to achieve the CBD's third objective. It examines the laws of those user countries which have either declared that their ABS obligations are satisfied by existing national law, or have begun legislative development; the requirements, weaknesses and gaps in achieving benefit-sharing objectives; and the ways in which new or existing legal tools can be applied to these requirements.
Author: Irene Calboli
Publisher: Oxford University Press
ISBN: 0198826745
Category : Law
Languages : en
Pages : 913
Get Book Here
Book Description
This book offers a comprehensive overview of the methods and approaches that could be used as guidelines to address and develop scholarly research questions related to intellectual property law, bringing together contributions from a diverse group of scholars who derive from a wide range of countries, backgrounds, and legal traditions.
Author: Joseph P. Stoltman
Publisher: SAGE
ISBN: 141297464X
Category : Science
Languages : en
Pages : 911
Get Book Here
Book Description
This is a theoretical and practical guide on how to undertake and navigate advanced research in the arts, humanities and social sciences.
Author: Jean d'Aspremont
Publisher: Cambridge University Press
ISBN: 110884510X
Category : Law
Languages : en
Pages : 403
Get Book Here
Book Description
Explores the possibilities and limits of the international legal architecture and its expert communities in shaping the world of tomorrow.
Author: Maria Sapignoli
Publisher: Cambridge University Press
ISBN: 1108126294
Category : Law
Languages : en
Pages : 441
Get Book Here
Book Description
This book presents a long-term study of the activist campaign that contested the Botswana government's much-publicized removal of the San and Bakgalagadi people from the Central Kalahari Game Reserve. Sapignoli's multiple points of observation and analysis range from rural Botswana to the nation's High Court, and a variety of United Nations agencies in their Headquarters, focusing on rights claimants and officials from NGOs, states and the United Nations as they acted on the grievances of those who had been displaced. In offering a comprehensive discussion of the San people and their claims-making through formal institutions, this book maintains a consistent focus on the increased recourse to law and the everyday experience of those who are asserting their rights in response to the encroachments of the state and the opportunities inherent in new indigenous advocacy networks.
Author: Charles Wambebe
Publisher: CRC Press
ISBN: 1351710494
Category : Medical
Languages : en
Pages : 198
Get Book Here
Book Description
Despite the relevance of and empirical evidence for African Traditional Medicine, based on African Indigenous Medical Knowledge (AIMK), research and development of new phytomedicines from this continent has been slow. African Indigenous Medical Knowledge and Human Health aims to provide a catalyst for health innovations based on the rich African biodiversity and AIMK. The book documents some of the success stories from the continent related to AIMK and serves as a one-step reference for all professionals interested in the research and development of medical interventions - including pharmacognosists, ethnobiologists, botanists, phytochemists, pharmacologists and medical scientists.
Author:
Publisher:
ISBN:
Category : Communicable diseases
Languages : en
Pages : 1058
Get Book Here
Book Description
Author: Doris Schroeder
Publisher: Springer Science & Business Media
ISBN: 9400762054
Category : Law
Languages : en
Pages : 250
Get Book Here
Book Description
Biomedical research is increasingly carried out in low- and middle-income countries. International consensus has largely been achieved around the importance of valid consent and protecting research participants from harm. But what are the responsibilities of researchers and funders to share the benefits of their research with research participants and their communities? After setting out the legal, ethical and conceptual frameworks for benefit sharing, this collection analyses seven historical cases to identify the ethical and policy challenges that arise in relation to benefit sharing. A series of recommendations address possible ways forward to achieve justice for research participants in low- and middle-income countries.
